glp 1 agonist drugs list Comparing Ozempic, Wegovy and Other GLP-1 glp-1 agonist drugs list GLP-1

In summary, GLP-1 drugs offer significant advantages for individuals with type 2 diabetes or weight management concerns

In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo

About half support the use of GLP-1 weight loss drugs for adults with obesity or weight-related conditions, and a similar share the belief that these drugs should be covered by Medicare and Medicaid.

A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.

The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gutrenal axis and incretin-based therapies might reduce the burden of diabetic kidney disease